TamaBio will sponsor the 26th Annual Meeting of the Japanese Society of Molecular Neurosurgery and provide support for the Presentation of Research Findings regarding the Recovery of Brain Tissue and Neurological Function.
The 26th Annual Meeting of the Japan Society of Molecular Neurosurgery :
2026/7/31(Fri), 8/1(Sat)
At : Akrie Himeji アクリエひめじ
〒670-0836 143-2 Kamiyacho Himeji-shi Hyogo Japan
TEL：+81 79-263-8082
https://www.himeji-ccc.jp/
President : Takashi Sasayama (Professor, Department of Neurosurgery, Division of Surgery, Graduate School of Medicine, Kobe University)
Theme: Shaping the Future of Neurosurgery
https://jsmn2026.umin.ne.jp/kaisai.html
For further details, please contact us using the inquiry form below or by contacting us directly.
Tetsuya Nagao／TamaBio Co.,Ltd. (MSE, Managing Director/CEO)
Registered (Tokyo) : A Class 1 Medical Devices Manufacturer & Distributor
PMDA Approval (DuraBeam® and PeriBeam®) : Class IV Highly Managed Medical Device
FDA Regulation Number : 870.3470, Classification Product Code DXZ
FDA Registration Number : 3041851334
Mobile +81 80 1196 3206 / Tel +81 422 53 5051 / FAX +81 422 38 5091
https://tamabio.com/en/
402 2-2-18 Sakai Musashino-shi Tokyo 180-0022 Japan